Autopsy report · NCT03328130

Safety and Efficacy Study in Patients With Retinitis Pigmentosa Due to Mutations in PDE6B Gene

Cause of deathFunding or business Automatic label, confidence 0.9, unverified. How labels are made.

“lack of financing”

The sponsor’s own words in the registry.

Life of this trial

Registered 1 month before it started.
Ran for about 7 years 8 months before it stopped.
19 participants enrolled.
No results are posted on the registry.

Vital statistics

Status: Terminated
Phase: Phase 1, Phase 2
Sponsor: eyeDNA Therapeutics
Sponsor type: Industry
Conditions: Retinitis Pigmentosa
Interventions: AAV2/5-hPDE6B
Participants: 19
Sites: 1
Countries: France

Trials that died the same way

Study of an Autologous Neo-Kidney Augment in Patients With Chronic Kidney Disease
“lack of funding” (83% match in meaning)

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.